Article | June 9, 2025

Separation Anxiety: Exploring The Challenges Of Cell Dissociation In Vaccine Manufacturing

Vaccine Manufacturing GettyImages-1384850913

To safely and rapidly produce vaccines, manufacturers often rely on trusted methods and popular adherent cell lines like Vero, MDCK, and MRC-5. A critical step in this process is cell dissociation, where cells are detached to support continued growth, scale-up, and harvesting. The three main methods to achieve this are mechanical, chemical, and enzymatic dissociation. While enzymatic agents like trypsin are popular for their efficiency, they are not without challenges. As an animal-origin product, trypsin can introduce variability and impurities, potentially impacting yield and even product safety. This has led many to consider animal-origin-free alternatives to improve consistency and supply.

To learn how innovative dissociation agents can optimize your workflow, read the full article.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Pharmaceutical Online